GPER-1 agonist G1 induces vasorelaxation through activation of epidermal growth factor receptor-dependent signalling pathway

Pharmacology, Toxicology and Pharmaceutical Science

• 1,3-Butadiene 20%
• 2 Morpholino 8 Phenylchromone 20%
• 4 (3 Chloroanilino) 6,7 Dimethoxyquinazoline 20%
• Epidermal Growth Factor Receptor 100%
• Estrogen Receptor Antagonist 40%
• G Protein Coupled Receptor 30 100%
• Heparin Binding Epidermal Growth Factor 20%
• Mitogen Activated Protein Kinase 20%
• N(g) Nitroarginine 20%
• Nitric Oxide 20%
• Phosphatidylinositol 3 Kinase Inhibitor 20%
• Phosphotransferase Inhibitor 20%
• Prostaglandin F2 20%
• Protein Kinase B Inhibitor 20%
• Receptor Blocking Agent 20%